Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

65.93
-0.5250-0.79%
Volume:14.99M
Turnover:991.53M
Market Cap:292.64B
PE:20.98
High:68.83
Open:68.81
Low:64.18
Close:66.45
Loading ...

Deutsche Bank Sticks to Its Buy Rating for Novo Nordisk (0QIU)

TIPRANKS
·
22 Apr

Trump Administration Weighs Drug Price Caps Tied to Global Rates, Alarming Industry

Tiger Newspress
·
22 Apr

Novo Nordisk (0QIU) Receives a Buy from Goldman Sachs

TIPRANKS
·
22 Apr

Stocks to Watch Tuesday: Tesla, Novo Nordisk, Hertz -- WSJ

Dow Jones
·
22 Apr

Novo Nordisk Shares Fall After Data From New Eli Lilly Pill

Dow Jones
·
22 Apr

Is Novo Nordisk A/S (NVO) The Top Falling Stock with Unusual Volume?

Insider Monkey
·
22 Apr

Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note

Zacks
·
22 Apr

Novo submits obesity pill for FDA approval, BioPharma Dive reports

TIPRANKS
·
22 Apr

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

Zacks
·
21 Apr

Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic's Competition Grows -- Barrons.com

Dow Jones
·
19 Apr

Novo Nordisk downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
18 Apr

Novo Nordisk downgraded by BMO as Eli Lilly gains ground in weight-loss drug race

Investing.com
·
18 Apr

Jefferies Sticks to Its Sell Rating for Novo Nordisk (0QIU)

TIPRANKS
·
18 Apr

J.P. Morgan Sticks to Its Buy Rating for Novo Nordisk (0QIU)

TIPRANKS
·
18 Apr

Novo Nordisk's ADRs Slide After Eli Lilly Obesity Pill Results -- Market Talk

Dow Jones
·
17 Apr

Eli Lilly's weight loss pill could be just as good as Ozempic — and the stock soars

Quartz
·
17 Apr

European Equities Traded in the US as American Depositary Receipts Modestly Higher in Thursday Trading

MT Newswires Live
·
17 Apr

Stock Track | Novo Nordisk Plummets 8% Pre-market on Analyst Downgrade and Rival's Breakthrough in Weight Loss Market

Stock Track
·
17 Apr

Stock Track | Novo Nordisk Plummets 8.08% as Analyst Downgrades and Rival's Breakthrough Shake Investor Confidence

Stock Track
·
17 Apr

Eli Lilly Shares Soar 14% as Lilly Pill Leads To 7.9% Weight Loss In Late-Stage Trial

Reuters
·
17 Apr